Septic Shock after Seasonal Influenza Vaccination in an HIV-Infected Patient during Treatment with Etanercept for Rheumatoid Arthritis: a Case Report

Walker, 2008, Rheumatic conditions in human immunodeficiency virus infection, Rheumatology (Oxford), 47, 952, 10.1093/rheumatology/ken132

Reveille, 2006, Infection and musculoskeletal conditions: rheumatologic complications of HIV infection, Best Pract. Res. Clin. Rheumatol., 20, 1159, 10.1016/j.berh.2006.08.015

Bachmann, 2010, Safety and efficacy of the tumor necrosis factor antagonists, Semin. Cutan. Med. Surg., 29, 35, 10.1016/j.sder.2010.02.002

Kaur, 2007, Successful etanercept use in an HIV-positive patient with rheumatoid arthritis, J. Clin. Rheumatol., 13, 79, 10.1097/01.rhu.0000260411.75599.39

Cepeda, 2008, The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease, Ann. Rheum. Dis., 67, 710, 10.1136/ard.2007.081513

Galeazzi, 2008, Treatment of rheumatic diseases in patients with HCV and HIV infection, Autoimmun. Rev., 8, 100, 10.1016/j.autrev.2008.07.009

Mikhail, 2008, Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus, Arch. Dermatol., 144, 453, 10.1001/archderm.144.4.453

Domm, 2008, The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature, Br. J. Dermatol., 159, 1217, 10.1111/j.1365-2133.2008.08851.x

Giannitti, 2009, Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection, Int. J. Immunopathol. Pharmacol., 22, 543, 10.1177/039463200902200233

Giannitti, 2011, Safety of anti-tumor necrosis factor agents in rheumatic potential carriers of occult hepatitis B virus, J. Rheumatol., 38, 780, 10.3899/jrheum.101157

Favalli, 2009, Serious infections during anti-TNF alpha treatment in rheumatoid arthritis patients, Autoimmun. Rev., 8, 266, 10.1016/j.autrev.2008.11.002

Nuñez-Cornejo, 2008, Septic shock and community-acquired pneumonia associated with etanercept therapy, Int. J. Clin. Pharmacol. Ther., 46, 193, 10.5414/CPP46193

Zimmer, 2006, Lethal acute respiratory distress syndrome during anti-TNF-alpha therapy for rheumatoid arthritis, Clin. Rheumatol., 25, 430, 10.1007/s10067-005-0008-1

Maimon, 2007, Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept, Thorax, 62, 739, 10.1136/thx.2005.056952

Aboulafia, 2000, Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis, Mayo Clin. Proc., 75, 1093, 10.4065/75.10.1093

Favero, 2009, Septic arthritis caused by Rothia dentocariosa in a patient with rheumatoid arthritis receiving etanercept therapy, J. Rheumatol., 36, 2846, 10.3899/jrheum.090276

Duchet-Niedziolka, 2009, Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey, Vaccine, 27, 1523, 10.1016/j.vaccine.2009.01.003

Rahier, 2010, Vaccinations in patients with immune-mediated inflammatory diseases, Rheumatology (Oxford), 49, 1815, 10.1093/rheumatology/keq183

Fiore, 2010, Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010, MMWR Recomm. Rep. 59(RR-8), 1

Kapetanovic, 2007, Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients, Rheumatology (Oxford), 46, 608, 10.1093/rheumatology/kel366

Gelinck, 2008, The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination, Ann. Rheum. Dis., 67, 713, 10.1136/ard.2007.077552

Fomin, 2006, Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers, Ann. Rheum. Dis., 65, 191, 10.1136/ard.2005.036434

Shoenfeld, 2011, ‘ASIA’—autoimmune/inflammatory syndrome induced by adjuvants, J. Autoimmun., 36, 4, 10.1016/j.jaut.2010.07.003

De Keyser, 2011, Choice of biologic therapy for patients with rheumatoid arthritis: the infection perspective, Curr. Rheumatol. Rev., 7, 77, 10.2174/157339711794474620